These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 10580056

  • 1. Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of vif for optimal infectivity: functional difference between Vif and Nef.
    Akari H, Uchiyama T, Fukumori T, Iida S, Koyama AH, Adachi A.
    J Gen Virol; 1999 Nov; 80 ( Pt 11)():2945-2949. PubMed ID: 10580056
    [Abstract] [Full Text] [Related]

  • 2. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.
    Aiken C.
    J Virol; 1997 Aug; 71(8):5871-7. PubMed ID: 9223476
    [Abstract] [Full Text] [Related]

  • 3. Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions.
    Cervantes-Acosta G, Lodge R, Lemay G, Cohen EA.
    J Hum Virol; 2001 Aug; 4(5):249-59. PubMed ID: 11907382
    [Abstract] [Full Text] [Related]

  • 4. gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.
    D'Aloja P, Olivetta E, Bona R, Nappi F, Pedacchia D, Pugliese K, Ferrari G, Verani P, Federico M.
    J Virol; 1998 May; 72(5):4308-19. PubMed ID: 9557721
    [Abstract] [Full Text] [Related]

  • 5. Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity.
    Chazal N, Singer G, Aiken C, Hammarskjöld ML, Rekosh D.
    J Virol; 2001 Apr; 75(8):4014-8. PubMed ID: 11264394
    [Abstract] [Full Text] [Related]

  • 6. Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: implications for HIV-based gene transfer systems.
    Luo T, Douglas JL, Livingston RL, Garcia JV.
    Virology; 1998 Feb 15; 241(2):224-33. PubMed ID: 9499797
    [Abstract] [Full Text] [Related]

  • 7. Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles.
    Pizzato M, Popova E, Göttlinger HG.
    J Virol; 2008 Nov 15; 82(21):10811-9. PubMed ID: 18715908
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription.
    Khan M, Garcia-Barrio M, Powell MD.
    J Virol; 2001 Dec 15; 75(24):12081-7. PubMed ID: 11711598
    [Abstract] [Full Text] [Related]

  • 16. [Functional roles of HIV-1 accessory genes for its pathogenicity].
    Adachi A, Kamada K, Hatcho K, Yamashita T, Uchiyama T, Nomaguchi M.
    Tanpakushitsu Kakusan Koso; 2007 Aug 15; 52(10 Suppl):1261-7. PubMed ID: 17824250
    [No Abstract] [Full Text] [Related]

  • 17. Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function.
    Simon JH, Miller DL, Fouchier RA, Malim MH.
    Virology; 1998 Sep 01; 248(2):182-7. PubMed ID: 9721227
    [Abstract] [Full Text] [Related]

  • 18. Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group.
    Rhodes DI, Ashton L, Solomon A, Carr A, Cooper D, Kaldor J, Deacon N.
    J Virol; 2000 Nov 01; 74(22):10581-8. PubMed ID: 11044102
    [Abstract] [Full Text] [Related]

  • 19. HIV accessory proteins: multifunctional components of a complex system.
    Bour S, Strebel K.
    Adv Pharmacol; 2000 Nov 01; 48():75-120. PubMed ID: 10987089
    [No Abstract] [Full Text] [Related]

  • 20. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein.
    Pandori MW, Fitch NJ, Craig HM, Richman DD, Spina CA, Guatelli JC.
    J Virol; 1996 Jul 01; 70(7):4283-90. PubMed ID: 8676450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.